If you’re a healthcare professional, chances are that you’ve already seen hundreds of patients suffering from sinusitis since 30 million patients suffer from the condition.1 Visit IntersectENT.com to learn more about how minimally invasive sinus surgery with the PROPEL® sinus stent can provide relief to people with chronic sinusitis.VISIT INTERSECTENT.COM
Surgical Techniques and Post-operative Practices Have Evolved, Thereby Improving Outcomes
In recent years, a medical advance has offered a new way for ENT physicians to keep the sinuses open after surgery. It’s a small spring-like device called the PROPEL sinus stent that ENT physicians place in the sinus following surgery.
PROPEL® is designed to prop the sinus open, deliver an advanced steroid directly to the healing sinus tissue and then bioabsorb so that removal is not required.
In terms of comfort, most patients cannot feel the stent. And because the steroid is delivered locally, there are no systemic side effects like those encountered with oral steroids.2
The PROPEL Sinus Stent is the first of a new category of products that offers localized, sustained, controlled drug delivery directly to the sinus tissue
Reducing the need for additional post-surgery interventions and oral steroid medications by 35%.1
Reducing polyp formation (harmless non-cancerous growths) by 46%.1
Dissolves over approximately 30–45 days.
PROPEL sets a new standard in maximizing outcomes following sinus surgery.
When the PATH to HEALING
Leads to Surgery
When the symptoms of chronic sinusitis do not respond to medical therapy, the patient will often be referred to an ENT physician for further evaluation. The ENT will assess patient anatomy, degree of inflammation and whether the symptoms are chronic in nature to determine whether endoscopic sinus surgery may be a recommended treatment path for the patient. Sinus surgery has evolved and is now minimally invasive, uses dissolvable packing rather than gauze packing, and has a shorter recovery period.2
1. Han JK, Marple BF, Smith TL et. al., Int. Forum Allergy Rhinol. 2012; 2:271-279
2. Govindaraj S, et al. Endoscopic sinus surgery: evolution and technical innovations. The Journal of Laryngology & Otology, 2010; 124:242-250
The purpose of the site is to help create awareness about sinusitis and treatment options for the disease. Please note that information contained on this site is not medical advice. It should not be used as a substitute for speaking with your physician. Always talk with your physician about diagnosis and treatment information.
The PROPEL sinus implants are intended for use after sinus surgery to maintain patency and to locally deliver steroids to the sinus mucosa: PROPEL for use in the ethmoid sinus, PROPEL Mini for use in the ethmoid sinus and frontal sinus opening, and PROPEL Contour for use in the frontal and maxillary sinus ostia. The implants are intended for use in patients ≥18 years of age. Contraindications include patients with intolerance to mometasone furoate (MF) or a hypersensitivity to bioabsorbable polymers. Safety and effectiveness of the implants in pregnant or nursing females have not been studied. Risks may include, but are not limited to, pain/pressure, displacement of implant, possible side effects of intranasal MF, sinusitis, epistaxis, and infection. For complete prescribing information see IFU at www.IntersectENT.com. Rx only.